Cargando…

Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging

Knowledge about potential differences in infarct tissue characteristics between patients with prior life-threatening ventricular arrhythmia versus patients receiving prophylactic implantable cardioverter-defibrillator (ICD) might help to improve the current risk stratification in myocardial infarcti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olimulder, Marlon A. G. M., Kraaier, Karin, Galjee, Michel A., Scholten, Marcoen F., van Es, Jan, Wagenaar, Lodewijk J., van der Palen, Job, von Birgelen, Clemens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550703/ https://www.ncbi.nlm.nih.gov/pubmed/22684301 http://dx.doi.org/10.1007/s10554-012-0077-6

Ejemplares similares

Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast enhancement cardiovascular magnetic resonance imaging study
por: Olimulder, Marlon A, et al.
Publicado: (2011)

Preservation of the relation between infarct characteristics and left ventricular remodeling following successful early revascularization for myocardial infarction: an observational study with contrast-enhanced cardiovascular MRI
por: Olimulder, Marlon A, et al.
Publicado: (2011)

Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
por: Olimulder, M. A. G. M., et al.
Publicado: (2011)

Association of Psychiatric History and Type D Personality with Symptoms of Anxiety, Depression, and Health Status Prior to ICD Implantation
por: Starrenburg, Annemieke H., et al.
Publicado: (2012)

Chronic fatigue syndrome in women assessed with combined cardiac magnetic resonance imaging
por: Olimulder, M. A. G. M., et al.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

Predictors of early mortality in implantable cardioverter-defibrillator recipients
por: Stein, Kenneth M., et al.
Publicado: (2009)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients
por: Cheema, Aamir, et al.
Publicado: (2010)

Arrhythmic triad in an implantable cardioverter‐defibrillator recipient with severe hypokalemia
por: Ciriello, Giovanni Domenico, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

A rare case of acute myocardial infarction during extraction of a septally placed implantable cardioverter-defibrillator lead
por: Wierda, Eric, et al.
Publicado: (2017)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Prevention of Early Sudden Cardiac Death after Myocardial Infarction Using the Wearable Cardioverter Defibrillator—Results from a Real-World Cohort
por: Rohrer, Ursula, et al.
Publicado: (2023)

Predictors of Mortality Amongst Recipients of Implantable Cardioverter Defibrillators for Secondary Prevention of Cardiac Arrest
por: Agarwal, Sunil K, et al.
Publicado: (2007)

Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease
por: El-Chami, Mikhael F., et al.
Publicado: (2017)

Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter‐defibrillator recipients
por: Burger, Achim Leo, et al.
Publicado: (2019)

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients
por: Olausson, Eric, et al.
Publicado: (2023)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Non-response to Implantable Cardioverter Defibrillator in a Post-Infarction Patient with Recurrent Ventricular Tachycardia After Catheter Ablation
por: Feng, Xiang-Fei, et al.
Publicado: (2015)

Acute ST-Segment Elevation Myocardial Infarction as a Rare Postoperative Complication of Biventricular Implantable Cardioverter-Defibrillator Placement
por: Phogat, Vishal, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
por: van Welsenes, G. H., et al.
Publicado: (2010)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS)
por: Kraaier, K., et al.
Publicado: (2014)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Frequency and clinical impact of retained implantable cardioverter defibrillator lead materials in heart transplant recipients
por: Kim, Jun, et al.
Publicado: (2017)

Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators
por: Tan, Nigel S., et al.
Publicado: (2021)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator
por: Alzand, B. S. N., et al.
Publicado: (2011)

Wearable cardioverter-defibrillators after myocardial infarction: a review of its clinical utility and unmet needs in current clinical practice
por: Hioki, Hirofumi, et al.
Publicado: (2021)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hj1h09u9muv0u9cm93199q6370